NIH names Jeanne Marrazzo to lead top US infectious diseases agency
02 Aug 2023
Executive ChangeVaccine
The US National Institutes of Health (NIH) on Wednesday announced that Jeanne Marrazzo has been selected to run the National Institute of Allergy and Infectious Diseases (NIAID)Infectious Diseases (NIAID). The incoming director, currently head of the infectious diseases division at the University of Alabama, takes up her new role in the fall and succeeds Anthony Fauci, who led the NIH unit for 38 years before stepping down last December.
With an annual budget of $6.3 billion, NIAID is the second largest of the NIH's 27 institutes and centres, after the National Cancer InstituteCancer Institute. Acting NIH director Lawrence Tabak stated that Marrazzo "brings a wealth of leadership experience from leading international clinical trials and translational research, managing a complex organisational budget that includes research funding and mentoring trainees in all stages of professional development."
Her scientific work has focused on the human microbiome, specifically as it relates to female reproductive tract infections and hormonal contraception, as well as the prevention of HIV infection using biomedical interventions, including PrEP and microbicides, and the pathogenesis and management of bacterial vaginosis, sexually transmitted diseases in HIV-infected patients and management of antibiotic resistance in gonorrhoea.
NIAID supports research at universities and research organisations around the US and across the unit's 21 laboratories, including the Vaccine Research Center where Ted Pierson was recently appointed director. It is also mandated to respond to emerging and re-emerging public health threats in the US and abroad. Hugh Auchincloss has been acting director of NIAID since Fauci's departure at the end of last year. The NIH can install Marrazzo in the post without a presidential appointment or confirmation by the US Senate.
Meanwhile, the Biden administration has not been able to secure a permanent appointment to run the broader NIH agency after long-time director Francis Collins stepped down at the end of 2021. Monica Bertagnolli was nominated in May, but Senator Bernie Sanders has said he will not hold a hearing on any health nominee until he sees a "robust" plan from the White House about lowering drug prices.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.